Cargando…
The chemokine CCL17 is a novel therapeutic target for cardiovascular aging
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113193/ https://www.ncbi.nlm.nih.gov/pubmed/37072419 http://dx.doi.org/10.1038/s41392-023-01363-1 |
| _version_ | 1785027784432680960 |
|---|---|
| author | Zhang, Yang Tang, Xiaoqiang Wang, Zeyuan Wang, Lun Chen, Zhangwei Qian, Ju-Ying Tian, Zhuang Zhang, Shu-Yang |
| author_facet | Zhang, Yang Tang, Xiaoqiang Wang, Zeyuan Wang, Lun Chen, Zhangwei Qian, Ju-Ying Tian, Zhuang Zhang, Shu-Yang |
| author_sort | Zhang, Yang |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10113193 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101131932023-04-20 The chemokine CCL17 is a novel therapeutic target for cardiovascular aging Zhang, Yang Tang, Xiaoqiang Wang, Zeyuan Wang, Lun Chen, Zhangwei Qian, Ju-Ying Tian, Zhuang Zhang, Shu-Yang Signal Transduct Target Ther Letter Nature Publishing Group UK 2023-04-19 /pmc/articles/PMC10113193/ /pubmed/37072419 http://dx.doi.org/10.1038/s41392-023-01363-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Letter Zhang, Yang Tang, Xiaoqiang Wang, Zeyuan Wang, Lun Chen, Zhangwei Qian, Ju-Ying Tian, Zhuang Zhang, Shu-Yang The chemokine CCL17 is a novel therapeutic target for cardiovascular aging |
| title | The chemokine CCL17 is a novel therapeutic target for cardiovascular aging |
| title_full | The chemokine CCL17 is a novel therapeutic target for cardiovascular aging |
| title_fullStr | The chemokine CCL17 is a novel therapeutic target for cardiovascular aging |
| title_full_unstemmed | The chemokine CCL17 is a novel therapeutic target for cardiovascular aging |
| title_short | The chemokine CCL17 is a novel therapeutic target for cardiovascular aging |
| title_sort | chemokine ccl17 is a novel therapeutic target for cardiovascular aging |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113193/ https://www.ncbi.nlm.nih.gov/pubmed/37072419 http://dx.doi.org/10.1038/s41392-023-01363-1 |
| work_keys_str_mv | AT zhangyang thechemokineccl17isanoveltherapeutictargetforcardiovascularaging AT tangxiaoqiang thechemokineccl17isanoveltherapeutictargetforcardiovascularaging AT wangzeyuan thechemokineccl17isanoveltherapeutictargetforcardiovascularaging AT wanglun thechemokineccl17isanoveltherapeutictargetforcardiovascularaging AT chenzhangwei thechemokineccl17isanoveltherapeutictargetforcardiovascularaging AT qianjuying thechemokineccl17isanoveltherapeutictargetforcardiovascularaging AT tianzhuang thechemokineccl17isanoveltherapeutictargetforcardiovascularaging AT zhangshuyang thechemokineccl17isanoveltherapeutictargetforcardiovascularaging AT zhangyang chemokineccl17isanoveltherapeutictargetforcardiovascularaging AT tangxiaoqiang chemokineccl17isanoveltherapeutictargetforcardiovascularaging AT wangzeyuan chemokineccl17isanoveltherapeutictargetforcardiovascularaging AT wanglun chemokineccl17isanoveltherapeutictargetforcardiovascularaging AT chenzhangwei chemokineccl17isanoveltherapeutictargetforcardiovascularaging AT qianjuying chemokineccl17isanoveltherapeutictargetforcardiovascularaging AT tianzhuang chemokineccl17isanoveltherapeutictargetforcardiovascularaging AT zhangshuyang chemokineccl17isanoveltherapeutictargetforcardiovascularaging |